serw-MX  [xml]  
 


    
 DeCS Categories

A08 Nervous System .
A08.675 Neurons .
A11 Cells .
A11.671 Neurons .
C03 Parasitic Diseases .
C03.105 Central Nervous System Parasitic Infections .
C03.105.250 Central Nervous System Helminthiasis .
C03.105.250.550 Neurocysticercosis .
C03.335 Helminthiasis .
C03.335.190 Cestode Infections .
C03.335.190.902 Taeniasis .
C03.335.190.902.185 Cysticercosis .
C03.335.190.902.185.550 Neurocysticercosis .
C04 Neoplasms .
C04.557 Neoplasms by Histologic Type .
C04.557.465 Neoplasms, Germ Cell and Embryonal .
C04.557.465.625 Neuroectodermal Tumors .
C04.557.465.625.600 Neoplasms, Neuroepithelial .
C04.557.465.625.600.580 Neurocytoma .
C04.557.470 Neoplasms, Glandular and Epithelial .
C04.557.470.670 Neoplasms, Neuroepithelial .
C04.557.470.670.580 Neurocytoma .
C04.557.580 Neoplasms, Nerve Tissue .
C04.557.580.625 Neuroectodermal Tumors .
C04.557.580.625.600 Neoplasms, Neuroepithelial .
C04.557.580.625.600.580 Neurocytoma .
C04.588 Neoplasms by Site .
C04.588.614 Nervous System Neoplasms .
C04.588.614.250 Central Nervous System Neoplasms .
C04.588.614.250.195 Brain Neoplasms .
C04.588.614.250.195.648 Neurocytoma .
C10 Nervous System Diseases .
C10.228 Central Nervous System Diseases .
C10.228.140 Brain Diseases .
C10.228.140.211 Brain Neoplasms .
C10.228.140.211.692 Neurocytoma .
C10.228.228 Central Nervous System Infections .
C10.228.228.205 Central Nervous System Parasitic Infections .
C10.228.228.205.250 Central Nervous System Helminthiasis .
C10.228.228.205.250.550 Neurocysticercosis .
C10.551 Nervous System Neoplasms .
C10.551.240 Central Nervous System Neoplasms .
C10.551.240.250 Brain Neoplasms .
C10.551.240.250.550 Neurocytoma .
D02 Organic Chemicals .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.779 Spiro Compounds .
D02.455.426.779.120 Buspirone .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.606 Piperazines .
D03.383.606.210 Buspirone .
D03.383.742 Pyrimidines .
D03.383.742.120 Buspirone .
D04 Polycyclic Compounds .
D04.711 Spiro Compounds .
D04.711.120 Buspirone .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.395 Glycoproteins .
D12.776.395.550 Membrane Glycoproteins .
D12.776.395.550.200 Cell Adhesion Molecules .
D12.776.395.550.200.250 Cell Adhesion Molecules, Neuronal .
D12.776.395.550.200.250.520 Neural Cell Adhesion Molecules .
D12.776.395.550.200.250.520.789 Neurocan .
D12.776.395.650 Proteoglycans .
D12.776.395.650.750 Chondroitin Sulfate Proteoglycans .
D12.776.395.650.750.687 Hyalectins .
D12.776.395.650.750.687.450 Neurocan .
D12.776.503 Lectins .
D12.776.503.280 Lectins, C-Type .
D12.776.503.280.437 Hyalectins .
D12.776.503.280.437.450 Neurocan .
D12.776.543 Membrane Proteins .
D12.776.543.550 Membrane Glycoproteins .
D12.776.543.550.200 Cell Adhesion Molecules .
D12.776.543.550.200.250 Cell Adhesion Molecules, Neuronal .
D12.776.543.550.200.250.520 Neural Cell Adhesion Molecules .
D12.776.543.550.200.250.520.789 Neurocan .
D23 Biological Factors .
D23.050 Antigens .
D23.050.301 Antigens, Surface .
D23.050.301.350 Cell Adhesion Molecules .
D23.050.301.350.250 Cell Adhesion Molecules, Neuronal .
D23.050.301.350.250.520 Neural Cell Adhesion Molecules .
D23.050.301.350.250.520.789 Neurocan .
SP4 Environmental Health .
SP4.001 Health .
SP4.001.012 Environmental Illness .
SP4.001.012.138 Parasitic Diseases .
SP4.001.012.138.119 Helminthiasis .
SP4.001.012.138.119.065 Cysticercosis .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Neurocysticercosis .
Brain Cysticercosis .
Neurocysticercoses .
Cysticercosis, Brain .
Central Nervous System Cysticercosis .
Cysticercosis, Central Nervous System .
Infection of the brain, spinal cord, or perimeningeal structures with the larval forms of the genus TAENIA (primarily T. solium in humans). Lesions formed by the organism are referred to as cysticerci. The infection may be subacute or chronic, and the severity of symptoms depends on the severity of the host immune response and the location and number of lesions. SEIZURES represent the most common clinical manifestation although focal neurologic deficits may occur. (From Joynt, Clinical Neurology, 1998, Ch27, pp46-50) .
1.00
 
Cysticercosis .
Cysticercoses .
Infection with CYSTICERCUS, the larval form of the various tapeworms of the genus Taenia (usually T. solium in man). In humans they penetrate the intestinal wall and invade subcutaneous tissue, brain, eye, muscle, heart, liver, lung, and peritoneum. Brain involvement results in NEUROCYSTICERCOSIS. .
0.66
 
Neurocan .
Chondroitin Sulfate Proteoglycan 3 .
A hyalectin family member that is expressed in neuronal tissue and plays a role in neuronal CELL ADHESION. .
0.53
122
 
Neurocytoma .
Central Neurocytoma .
Central Neurocytomas .
Neurocytomas .
Neurocytomas, Central .
Neurocytoma, Central .
A benign brain tumor composed of neural elements which most often arise from the SEPTUM PELLUCIDUM and the walls of the lateral ventricles. Immunohistochemistry and electron microscopy evaluations may reveal expression of neuron specific enolase and synaptophysin and cells containing microtubuli, neurosecretory granules, and presynaptic vesicles. (From Acta Med Port 1994 Feb;7(2):113-9) .
0.53
23549
 
Neurons .
Cell, Nerve .
Cells, Nerve .
Nerve Cell .
Neuron .
Nerve Cells .
The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. .
0.52
457236160
 
Buspirone .
Anxut .
Apo-Buspirone .
Bespar .
Busp 12664 .
Buspar .
Buspirone Hydrochloride .
Gen-Buspirone .
Lin-Buspirone .
MJ-9022-1 .
N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide .
Neurosine .
Novo-Buspirone .
Nu-Buspirone .
PMS-Buspirone .
Ratio-Buspirone .
Apo Buspirone .
Gen Buspirone .
Hydrochloride, Buspirone .
Lin Buspirone .
MJ 9022 1 .
MJ90221 .
Novo Buspirone .
Nu Buspirone .
PMS Buspirone .
Ratio Buspirone .
An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM. .
0.51
471830